Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRP.L Regulatory News (PRP)

  • There is currently no data for PRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

10 Sep 2020 07:00

RNS Number : 5427Y
Prime People PLC
10 September 2020
 

 

10 September 2020

 

Prime People plc

("Prime People" or the "Group")

 

Pre-Close Trading Update

 

Prime People Plc (AIM: PRP), the global specialist recruitment business for professional and technical staff working in the Real Estate & Built Environment, Energy & Environmental and Technology, Digital & Data Analytics sectors, provides a pre-close unaudited trading update for the financial year ended 31 March 2020 and confirms that it intends to announce final results for the year ended 31 March 2020 at the end of October 2020.

 

The Company expects to report headline Revenue of approximately £23.85 million (2019: £24.66 million) and Net Fee Income ("NFI") of approximately £15.38 million (2019: £15.78 million) for the year ended 31 March 2020 which is expected to result in a profit before tax and of not less than £1.80 million* (2019: £2.47 million).

 

The Group's audit is ongoing, and the Directors are evaluating goodwill impairment and are considering an impairment charge for the year to 31 March 2020. The final valuation and subsequent impact on net profit will be disclosed in the full year audited financial statements. In these extraordinary times, the Group's results may be subject to audit adjustments that are unknown to the Directors at the time of this announcement.

 

Net cash, excluding the CBILS loan, at the date of this announcement is £2.23 million, up from the year-end position of £2.05 million (2019: £2.31 million) and the Group is well positioned to meet its working capital requirements.

 

Post year end, and as announced on 15 April 2020, as a direct result of COVID-19 we experienced a significant reduction in demand across our businesses with the impact varying by location and sector. Early action was taken by the Board to implement a range of measures to protect our business from the financial impact of COVID-19 including managing staff costs through furlough and other governmental schemes in the countries in which we operate, reductions in remuneration, minimising discretionary spend and rigorous cashflow management.

 

The depth and speed of impact on the global economy of COVID-19 has been unprecedented. The Group's trading has been severely impacted in the first six months of the new financial year. We have acted swiftly to take the necessary actions to manage our cost base to reflect expected levels of business. Whilst this process is constantly under review, we consider we have taken the right decisions to secure our businesses. We have the necessary cashflows and bank support (including the CBILS loan announced on 12 June 2020) for the foreseeable future and business appears to have settled at a sustainable level.

 

As previously announced, in order to strengthen the balance sheet and aid liquidity, the Board has taken the prudent decision not to pay a final dividend for the year ending 31 March 2020. The Board remains committed to paying progressive dividends as soon as appropriate and when there is better clarity on the financial consequences of COVID-19. Further, the Board intends to exercise its share buyback authority, as approved at the Group's most recent annual general meeting, and it is expected that the Group will make market purchases of ordinary shares of 10 pence each in the capital of the Group with a value of up to £0.25 million. A further announcement in respect of the share buyback programme will be made by the Group in due course as appropriate.

* this figure does not include the impact of any goodwill impairment charges.

Peter Moore, Chief Executive Officer, commented:

"The initial financial effects of the global pandemic were experienced as early as January by our Asian business. The effect on our other businesses started to have impact in early March. Our current financial year will be significantly affected by the pandemic as a consequence of material reductions in NFI and new job instructions. In the first six months of trading UK NFI is circa 40% lower than the comparable period last year and job instructions down by 54%. Our Asia business has suffered a circa 26% reduction in NFI and a 26% fall in job instructions.

 

"Since June there has been a modest increase in activity. However, half and full year profitability will be severely impacted. As a result of challenging trading, we expect to take a material reduction in the value of goodwill on our balance sheet.

 

"At this time the Group holds a strong cash position aided by CBILS arrangements.

 

"I would like to thank all our staff for their unfailing support, hard work and commitment during these difficult times."

 

 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

For further information, please contact: 

 

Prime People

Robert Macdonald, Executive Chairman

020 7318 1785

Donka Zaneva-Todorinski, Finance Director

Cenkos Securities plc

020 7397 8900

Katy Birkin/Nick Wells/Harry Hargreaves

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLLMPTMTJMBJM
Date   Source Headline
24th Aug 201111:40 amRNSIssue of Equity
24th Aug 201111:20 amRNSShare Buy Back
6th Jul 20113:11 pmRNSShare Buy Back
28th Jun 201112:55 pmRNSAGM Statement
9th Jun 20114:30 pmRNSShare Buy Back
3rd Jun 20117:00 amRNSFinal Results
30th Mar 201112:07 pmRNSTransaction in Own Shares
12th Nov 20107:00 amRNSHalf Yearly Report
8th Jul 201010:08 amRNSResult of AGM
6th Jul 20109:39 amRNSAGM Statement
29th Jun 201011:23 amRNSTransaction in Own Shares
4th Jun 20103:55 pmRNSDirector/PDMR Shareholding
4th Jun 20107:00 amRNSFinal Results
19th Mar 20102:22 pmRNSDirector/PDMR Shareholding
18th Mar 20107:00 amRNSDividend Declaration
2nd Dec 20092:58 pmRNSTransaction in Own Shares
19th Nov 20097:00 amRNSHalf Yearly Report
28th Sep 20093:43 pmRNSDirector/PDMR Shareholding
14th Aug 200911:30 amRNSTransaction in Own Shares
7th Jul 200912:24 pmRNSResult of AGM and EGM
9th Jun 20097:00 amRNSCapital Reorganisation
8th Jun 20097:00 amRNSFinal Results
11th May 20097:00 amRNSChange of Adviser
19th Mar 20093:07 pmRNSDirector/PDMR Shareholding
12th Jan 20099:10 amRNSTrading Update
21st Nov 20087:00 amRNSInterim Results
24th Oct 20087:00 amRNSTrading Update
7th Aug 200811:05 amRNSHolding(s) in Company
30th Jul 20083:08 pmRNSResult of AGM
30th Jul 20087:00 amRNSAGM Statement
16th Jun 200810:42 amRNSAnnual Report and Accounts
6th Jun 20087:00 amRNSFinal Results
18th Apr 20087:00 amRNSTrading Statement
2nd Apr 20084:51 pmRNSHolding(s) in Company
26th Mar 20085:13 pmRNSHolding(s) in Company
3rd Dec 20074:28 pmRNSHolding(s) in Company
23rd Nov 20077:01 amRNSInterim Results
10th Oct 20077:01 amRNSClose Period Trading Update
16th Aug 20074:27 pmRNSAIM Rule 26 Compliance
18th Jul 20074:29 pmRNSResult of AGM
17th Jul 20077:00 amRNSAGM Statement
7th Jun 20077:01 amRNSFinal Results
3rd May 20077:01 amRNSTrading Statement
4th Apr 200711:00 amRNSChange of Adviser
29th Mar 200710:59 amRNSHolding(s) in Company
23rd Mar 200712:03 pmRNSHolding(s) in Company
20th Mar 20073:23 pmRNSDirector/PDMR Shareholding
29th Dec 20069:51 amRNSDirector/PDMR Shareholding
19th Dec 20063:54 pmRNSTotal Voting Rights
22nd Nov 20067:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.